Treating femoropopliteal disease: Established and emerging technologies

Seminars in Interventional Radiology

Volumn 31, Issue 4, 2014, Pages 345-352

  Diamantopoulos, Athanasios ^a   Katsanos, Konstantinos ^a  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

angioplasty; balloon; covered stent; drug eluting; femoropopliteal; interventional radiology; paclitaxel coated; restenosis; severe leg ischemia; stent; subintimal

Indexed keywords

ANGIOPLASTY; ARTICLE; BALLOON DILATATION; BARE METAL STENT; BIOMECHANICS; CLINICAL TRIAL (TOPIC); CRITICAL LIMB ISCHEMIA; DISEASE SEVERITY; DRUG ELUTING STENT; ENDOVASCULAR SURGERY; FEMORAL ARTERY; HUMAN; INTERMITTENT CLAUDICATION; KINESIOTHERAPY; LEG REVASCULARIZATION; META ANALYSIS (TOPIC); METAL STENT; NITINOL STENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POPLITEAL ARTERY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECANALIZATION; RESTENOSIS; SELF EXPANDABLE METALLIC STENT; SELF EXPANDING NITINOL STENT; SELF EXPANDING STENT; SURGICAL TECHNIQUE; SYSTEMATIC REVIEW (TOPIC); TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 84910136882     PISSN: 07399529     EISSN: 10988963     Source Type: Journal    
DOI: 10.1055/s-0034-1393971     Document Type: Article

References (30)

1. Kasapis C., Gurm H. S. Current approach to the diagnosis and treatment of femoral-popliteal arterial disease. A systematic review. Curr Cardiol Rev: 2009; 5 4 296 311
2. Dormandy J. A., Rutherford R. B. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg: 2000; 31 (1, Pt 2): S1 S296
3. Norgren L., Hiatt W. R., Dormandy J. A., et al. TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg: 2007; 33 01 S1 S75
4. Rooke T. W., Hirsch A. T., Misra S., et al. American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines; Society for Cardiovascular Angiography and Interventions; Society of Interventional Radiology; Society for Vascular Medicine; Society for Vascular Surgery. 2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society for Vascular Medicine, and Society for Vascular Surgery. J Vasc Surg: 2011; 54 5 e32 e58
5. Tendera M., Aboyans V., Bartelink M. L., et al. European Stroke Organisation; ESC Committee for Practice Guidelines. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology (ESC). Eur Heart J: 2011; 32 22 2851 2906
6. Murphy T. P., Reynolds M. R., Cohen D. J., et al. Correlation of patient-reported symptom outcomes and treadmill test outcomes after treatment for aortoiliac claudication. J Vasc Interv Radiol: 2013; 24 10 1427 1435, quiz 1436
7. Katsanos K., Tepe G., Tsetis D., Fanelli F. Standards of practice for superficial femoral and popliteal artery angioplasty and stenting. Cardiovasc Intervent Radiol: 2014; 37 3 592 603
8. Geronemus A. R., Peña C. S. Endovascular treatment of femoral-popliteal disease. Semin Intervent Radiol: 2009; 26 4 303 314
9. NICE. Clinical Guideline 147: Lower Limb Peripheral Arterial Disease: Diagnosis and Management. Available at: http://www.nice.org.uk
10. Bolia A., Brennan J., Bell P. R. Recanalisation of femoro-popliteal occlusions: improving success rate by subintimal recanalisation. Clin Radiol: 1989; 40 3 325
11. Reekers J. A., Bolia A. Percutaneous intentional extraluminal (subintimal) recanalization: how to do it yourself. Eur J Radiol: 1998; 28 3 192 198
12. Met R., Van Lienden K. P., Koelemay M. J., Bipat S., Legemate D. A., Reekers J. A. Subintimal angioplasty for peripheral arterial occlusive disease: a systematic review. Cardiovasc Intervent Radiol: 2008; 31 4 687 697
13. Katsanos K., Spiliopoulos S., Karunanithy N., Krokidis M., Sabharwal T., Taylor P. Bayesian network meta-analysis of nitinol stents, covered stents, drug-eluting stents, and drug-coated balloons in the femoropopliteal artery. J Vasc Surg: 2014; 59 4 1123 1133, e8
14. Cassese S., Byrne R. A., Ott I., et al. Paclitaxel-coated versus uncoated balloon angioplasty reduces target lesion revascularization in patients with femoropopliteal arterial disease: a meta-analysis of randomized trials. Circ Cardiovasc Interv: 2012; 5 4 582 589
15. Kasapis C., Henke P. K., Chetcuti S. J., et al. Routine stent implantation vs. percutaneous transluminal angioplasty in femoropopliteal artery disease: a meta-analysis of randomized controlled trials. Eur Heart J: 2009; 30 1 44 55
16. Kessel D. O., Samson R. H. What is the evidence for the efficacy of cryoplasty? J Cardiovasc Surg (Torino): 2008; 49 2 179 185
17. Spiliopoulos S., Katsanos K., Karnabatidis D., et al. Cryoplasty versus conventional balloon angioplasty of the femoropopliteal artery in diabetic patients: long-term results from a prospective randomized single-center controlled trial. Cardiovasc Intervent Radiol: 2010; 33 5 929 938
18. Muradin G. S., Bosch J. L., Stijnen T., Hunink M. G. Balloon dilation and stent implantation for treatment of femoropopliteal arterial disease: meta-analysis. Radiology: 2001; 221 1 137 145
19. Pastromas G., Katsanos K., Krokidis M., Karnabatidis D., Spiliopoulos S. Emerging stent and balloon technologies in the femoropopliteal arteries. ScientificWorldJournal: 2014; 2014 695402
20. Acin F., de Haro J., Bleda S., Varela C., Esparza L. Primary nitinol stenting in femoropopliteal occlusive disease: a meta-analysis of randomized controlled trials. J Endovasc Ther: 2012; 19 5 585 595
21. Perrio S., Holt P. J., Patterson B. O., Hinchliffe R. J., Loftus I. M., Thompson M. M. Role of superficial femoral artery stents in the management of arterial occlusive disease: review of current evidence. Vascular: 2010; 18 2 82 92
22. Duda S. H., Pusich B., Richter G., et al. Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results. Circulation: 2002; 106 12 1505 1509
23. Duda S. H., Bosiers M., Lammer J., et al. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial. J Endovasc Ther: 2006; 13 6 701 710
24. Dake M. D., Ansel G. M., Jaff M. R., et al. Zilver PTX Investigators. Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results. Circ Cardiovasc Interv: 2011; 4 5 495 504
25. Dake M. D., Ansel G. M., Jaff M. R., et al. Zilver PTX Investigators. Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the Zilver PTX randomized and single-arm clinical studies. J Am Coll Cardiol: 2013; 61 24 2417 2427
26. Saxon R. R., Dake M. D., Volgelzang R. L., Katzen B. T., Becker G. J. Randomized, multicenter study comparing expanded polytetrafluoroethylene-covered endoprosthesis placement with percutaneous transluminal angioplasty in the treatment of superficial femoral artery occlusive disease. J Vasc Interv Radiol: 2008; 19 6 823 832
27. Lammer J., Zeller T., Hausegger K. A., et al. Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease). J Am Coll Cardiol: 2013; 62 15 1320 1327
28. Diamantopoulos A., Gupta Y., Zayed H., Katsanos K. Paclitaxel-coated balloons and aneurysm formation in peripheral vessels. J Vasc Surg: 2014;; epub ahead of print
29. Vermassen F., Bouckenooghe I., Moreels N., Goverde P., Schroe H. Role of bioresorbable stents in the superficial femoral artery. J Cardiovasc Surg (Torino): 2013; 54 2 225 234
30. Werner M., Micari A., Cioppa A., et al. Evaluation of the biodegradable peripheral Igaki-Tamai stent in the treatment of de novo lesions in the superficial femoral artery: the GAIA study. JACC Cardiovasc Interv: 2014; 7 3 305 312